Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Erben

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
Translational Oncology|October 25, 2020
POFUT1 mRNA expression as an independent prognostic parameter in muscle-invasive bladder cancerSarah Wahby, Jonas Jarczyk, Alexander Fierek, et al.
Haematologica|June 7, 2007
Dynamics of cytogenetic aberrations in Philadelphia chromosome positive and negative hematopoiesis during dasatinib therapy of chronic myeloid leukemia patients after imatinib failureAlice Fabarius, Claudia Haferlach, Martin C Müller, et al.
Oncology Reports|January 21, 2011
Down-regulation of MMP-2 expression due to inhibition of receptor tyrosine kinases by imatinib and carboplatin in HNSCCJohannes D Schultz, Sarah Rotunno, Philipp Erben, et al.
Archives of Dermatology|June 20, 2007
Imatinib as a treatment option for systemic non-Langerhans cell histiocytosesJochen Utikal, Selma Ugurel, Hjalmar Kurzen, et al.
Haematologica|January 29, 2008
Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinibThomas Ernst, Philipp Erben, Martin C Müller, et al.
Molecular & Cellular Proteomics : MCP|April 12, 2017
Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer BiomarkerThomas Stefan Worst, Jost von Hardenberg, Julia Christina Gross, et al.
BMC Urology|September 20, 2017
The EEF1A2 gene expression as risk predictor in localized prostate cancerThomas Stefan Worst, Frank Waldbillig, Abdallah Abdelhadi, et al.
Urologia Internationalis|February 6, 2022
Upper Tract Urinary Cancer Recurrence after Radical Cystectomy: Risk Assessment of Intraoperative Frozen SectionMalin Nientiedt, Frank Waldbillig, Felix Stroop, et al.
Virchows Archiv : an International Journal of Pathology|November 29, 2018
Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladderPhilipp Erben, Danijel Sikic, Ralph M Wirtz, et al.
Cancer Immunology, Immunotherapy : CII|November 19, 2017
High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patientsJohannes Breyer, Ralph M Wirtz, Wolfgang Otto, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Translational Oncology|October 25, 2020
POFUT1 mRNA expression as an independent prognostic parameter in muscle-invasive bladder cancerSarah Wahby, Jonas Jarczyk, Alexander Fierek, et al.
Haematologica|June 7, 2007
Dynamics of cytogenetic aberrations in Philadelphia chromosome positive and negative hematopoiesis during dasatinib therapy of chronic myeloid leukemia patients after imatinib failureAlice Fabarius, Claudia Haferlach, Martin C Müller, et al.
Oncology Reports|January 21, 2011
Down-regulation of MMP-2 expression due to inhibition of receptor tyrosine kinases by imatinib and carboplatin in HNSCCJohannes D Schultz, Sarah Rotunno, Philipp Erben, et al.
Archives of Dermatology|June 20, 2007
Imatinib as a treatment option for systemic non-Langerhans cell histiocytosesJochen Utikal, Selma Ugurel, Hjalmar Kurzen, et al.
Haematologica|January 29, 2008
Dynamics of BCR-ABL mutated clones prior to hematologic or cytogenetic resistance to imatinibThomas Ernst, Philipp Erben, Martin C Müller, et al.
Molecular & Cellular Proteomics : MCP|April 12, 2017
Database-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer BiomarkerThomas Stefan Worst, Jost von Hardenberg, Julia Christina Gross, et al.
BMC Urology|September 20, 2017
The EEF1A2 gene expression as risk predictor in localized prostate cancerThomas Stefan Worst, Frank Waldbillig, Abdallah Abdelhadi, et al.
Urologia Internationalis|February 6, 2022
Upper Tract Urinary Cancer Recurrence after Radical Cystectomy: Risk Assessment of Intraoperative Frozen SectionMalin Nientiedt, Frank Waldbillig, Felix Stroop, et al.
Virchows Archiv : an International Journal of Pathology|November 29, 2018
Analysis of the prognostic relevance of sex-steroid hormonal receptor mRNA expression in muscle-invasive urothelial carcinoma of the urinary bladderPhilipp Erben, Danijel Sikic, Ralph M Wirtz, et al.
Cancer Immunology, Immunotherapy : CII|November 19, 2017
High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patientsJohannes Breyer, Ralph M Wirtz, Wolfgang Otto, et al.
Pageof 13